Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
RHI: Acqn of royalty over Sandstone Gold Project tenements

Related Posts

Altech – Agreement to Secure EUR2.5M in Funding

March 25, 2025

15 Canadian Crypto ETFs in 2025

August 12, 2025

Allied Critical Metals: Advancing Tungsten Projects in Portugal

June 21, 2025

NorthStar Gaming to Host Q2 2025 Earnings Webinar...

August 8, 2025

Preliminary data of Butembo Copper prospect, with near...

October 1, 2025

Juggernaut Exploration: Advancing High-grade Precious Metals Assets in...

June 12, 2025

RemSense Capital Raising

August 4, 2025

Copper Price Update: Q2 2025 in Review

July 25, 2025

Crypto Market Update: Stablecoins Top US$283 Billion in...

August 30, 2025

Lithium Prices Surge After CATL Halts Major Mine...

August 14, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved